Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials-MedSci.cn

Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials

Liu, JL; Li, L; Li, SY; Wang, YN; Qin, X; Deng, K; Liu, YM; Zou, K; Sun, X

Sun, X (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.

DIABETES OBESITY & METABOLISM, 2020; 22 (9): 1619

Abstract

Aim To assess the effects of sodium-glucoseco-transporter-2 (SGLT2) inhibitors on diabetic ketoacidosis (DKA) in patients with type 2 diabetes. Materi......

Full Text Link